News
Market and company headlines
CCELAll
Loading
16:00-18:00Oct 92 Stories
Cryo-Cell Intl (NYSEARCA:CCEL) Q3 Profit Surges Past Estimates on Flat Revenue
Cryo-Cell (CCEL) Q3 EPS crushed estimates at $0.16, but revenue stayed flat at $7.82M. See the profit surprise, market reaction, and key risks.
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2026 Financial Results
OLDSMAR, Fla., October 09, 2026--Cryo-Cell International, Inc. (NYSE American, Symbol: CCEL) (the "Company", "Cryo-Cell"), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended August 31, 2026.